Until Labs
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- $58M
Investors
- 3
About Until Labs
Based in the US, Until Labs, Inc.Until Labs is focused on transforming organ transplantation logistics through innovative cryopreservation methods.Until specializes in advanced cryopreservation technologies aimed at significantly extending the viability of donated human organs. Their core offering transforms the traditional hours of organ viability into weeks or months, addressing the critical logistical challenges faced in organ transplantation. By leveraging innovative cryopreservation techniques, Until aims to ensure that no donated organs are lost due to logistical delays, thereby preventing patient mortality due to waiting times. This technology serves a wide range of stakeholders within the medical community, including hospitals, transplant centers, and research institutions, primarily in North America and Europe, where the demand for organ transplants is highest.Until's revenue model is centered on the provision of its cryopreservation services to healthcare institutions, primarily through direct partnerships with hospitals and transplant centers. Revenue is generated through service agreements, which may include usage fees for the application of their technology and potential subscription models for ongoing access to their cryopreservation solutions. Specific pricing structures are tailored to the needs of each client, enabling a flexible approach that aligns with the varying capacities and requirements of healthcare providers. While the pricing details for individual services are proprietary, the strategic partnerships established with key healthcare organizations suggest a robust framework for revenue generation as the company scales its operations. The company is developing new cryopreservation products, aiming to enhance its offerings by expanding the range of services available to healthcare providers. Additionally, Until is targeting expansion into new markets, with a focus on increasing its presence in Europe and other high-demand regions by 2026, thereby aligning its growth strategy with rising organ transplantation needs.
Who invested in Until Labs
3 investors across 1 round
See all investors in Until Labs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 22, 2025
Amount
$58M
Investors
Questions about Until Labs
Who invested in Until Labs?
Until Labs has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Until Labs raised?
Until Labs has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Until Labs last raise money?
Until Labs's most recent round on record is a Series A, in Sep 2025.
What does Until Labs do?
Based in the US, Until Labs, Inc.
Where is Until Labs headquartered?
Until Labs is headquartered in San Francisco, US.
Which VCs invest in companies like Until Labs?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Until Labs's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Until Labs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.